The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis
Abstract
BACKGROUND: Conflicting results regarding adiponectin levels in women with polycystic ovary syndrome (PCOS) have been reported. To evaluate adiponectin levels in PCOS, a systematic review of all studies comparing adiponectin levels in women with PCOS with healthy controls and a meta-analysis of those involving women with similar body mass index (BMI) were performed. The influence of possible effect modifiers, such as insulin resistance (IR) and testosterone, was investigated. The influence of obesity was investigated through a 'nested' meta-analysis after within-study BMI stratification and appropriate pooling. METHODS: Literature search was conducted through MEDLINE, EMBASE, Cochrane CENTRAL (through June 2008), references from relevant studies and personal contact with the authors. Thirty-one studies, reporting data on 3469 subjects, were reviewed and 16 included in the main meta-analysis. RESULTS: Women with PCOS demonstrated significantly lower adiponectin values [weighted mean difference (95% confidence interval) -1.71 (-2.82 to -0.6), P < 10(-4)], yet with significant between-study heterogeneity. Lower adiponectin levels are associated with the IR observed in women with PCOS, compared with controls. IR, but not total testosterone, was found significant among biological parameters explored in the meta-regression model. Hypoadiponectinaemia was present in both lean and obese women with PCOS when compared with non-PCOS counterparts. Data on high molecular weight (HMW) adiponectin are limited (three studies). CONCLUSIONS: After controlling for BMI-related effects, adiponectin levels seem to be lower in women with PCOS compared with non-PCOS controls. Low levels of adiponectin in PCOS are probably related to IR but not to testosterone. Total adiponectin should not be used as a biomarker of PCOS severity. Further investigation is needed for HMW adiponectin levels in PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“after controlling for BMI-related effects, adiponectin levels appear to be lower in women with PCOS than in controls without PCOS [44].”
From PCOS and nutritional approaches: Differences between lean and obese phenotype (2021) · cites this paper as [44]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,377
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,840
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–261 of 261
Wang, Y., Xie, X.-M., Dai, M., & Zhu, W.-J. (2010) · Scientific Research and Essays · doi:10.5897/sre.9000798 · Cited by 4
Metabolic syndrome and female reproductive system (review)
Dyakonov (2016) · Russian Journal of Human Reproduction · doi:10.17116/repro201622237-43 · Cited by 5
Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome
Czeczuga-Semeniuk, E., Jarząbek, K., Galar, M., Kozłowski, P., Sarosiek, N. A., Zapolska, G., & Wołczyński, S. (2014) · Endocrine · doi:10.1007/s12020-014-0345-4 · Cited by 4
Wildman, R. P., Wang, D., Fernández, I., Mancuso, P., Santoro, N. F., Scherer, P. E., & Sowers, M. R. (2012) · Obesity · doi:10.1038/oby.2012.109 · Cited by 4
Obesity in polycystic ovary syndrome and infertility
Messinis, I. E., Messini, C. I., & Dafopoulos, K. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00003-6 · Cited by 4
Adiponectin and Polycystic Ovary Syndrome in Adolescent Girls: A Systematic Review and Meta-Analysis
Fernando, S., & Ramdass, P. V. A. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093950 · Cited by 3
“The present findings are broadly consistent with previous meta-analyses conducted in adult populations, which have similarly reported significantly lower adiponectin levels in women with PCOS compared to controls [9,10,14].”
Evaluation of Leptin and HOMA-Adiponectin in Hypothyroid Infertile Females
Senghor, K. A. A., Shivasekar, M., & Vinodhini, V. M. (2020) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2071 · Cited by 4
Obesity in PCOS and Infertility
Messinis, I. E., Messini, C. I., & Dafopoulos, K. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416045-3.00008-x · Cited by 3
Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
Eroğlu, S., & Çakmaklıoğulları, E. K. (2021) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2021.09.012 · Cited by 2
Interplay of adipocytokines with polycystic ovary syndrome
Baig, M., Ahmad, T., & Tariq, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00014-1 · Cited by 2
Estados hiperandrogénicos: revisión de la literatura
Villarreal-Tordecilla, G. A. (2009) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.319 · Cited by 2
Determination of Serum Adiponectin Levels in Normal Weight Women with Polycystic Ovary Syndrome
Hamdi, R. A., Mohammed, N. S., & Al-Naddawi, A. M. (2015) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/med.1936/jfacmedbagdad.v57i2.18 · Cited by 4
“A possible explanation for this finding is that lower adiponectin levels in PCOS women might be a result of increasing IR in these patients (27).”
BackgroundObesity and female infertility
Kini, S., Ramalingam, M., & Mahmood, T. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00009-7 · Cited by 2
Metabolic and lipoprotein aspects of polycystic ovarian syndrome
Pazderska, A., & Gibney, J. (2015) · Clinical Lipidology · doi:10.2217/clp.15.12 · Cited by 2
Kahal, H. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Serum adiponectin in Indian women with polycystic ovary syndrome
Rajendra, A. (2023) · Bioinformation · doi:10.6026/97320630019206 · Cited by 1
Serum adiponectin in women with polycystic ovary syndrome
Jahan, I. A., Morshed, M. S., Banu, H., Chowdhury, E. U. R., & Hasanat, M. A. (2023) · Bangladesh Journal of Medicine · doi:10.3329/bjm.v34i3.67393 · Cited by 1
Prevalence, Risk Factors and Management of Polycystic Ovary Syndrome: A Review with Current Evidence
Memon, S. I., Shakeel, M., Syed, H., Amin, K., Khalil, A. A., & Sulaiman, M. (2024) · Iraq Medical Journal · doi:10.22317/imj.v8i1.1268 · Cited by 1
“23 Furthermore, the development of PCOS is significantly influenced by environmental and lifestyle variables that are influenced by exposure to endocrine-disrupting chemicals and prenatal factors, with the presence of an unhealthy diet and sedentary behavior potentially exacerbating insulin…”
BackgroundBiomarkers for effective prognosis of polycystic ovary syndrome: a full review
Singh, I., Pant, A., & Maurya, P. K. (2026) · Biomarkers in Medicine · doi:10.1080/17520363.2026.2622044 · Cited by 1
Asociación entre adiponectina y el síndrome de ovario poliquístico. Revisión de la literatura
Bustamante-Zuluaga, C., Vergara-Quintero, F., & Díaz-Yúnez, I. (2013) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.122 · Cited by 1
“Sin embargo, dada la evidencia revisada, no es claro que sea pertinente en la actualidad solicitar una adiponectina sérica como un laboratorio de rutina en el SOP (50).”
BackgroundOcena stężenia wybranych adipocytokin u chorych z zespołem metabolicznym i nadciśnieniem tętniczym
Foremska-Iciek, J. (2010) · Biblioteka Uniwersytetu Medycznego w Poznaniu · Cited by 1
Adipose Tissue Dysfunction in PCOS
Aparupa, A., & Singh, R. (2024) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34082 · Cited by 1
Mengensatzproduktion, S., Stückle, D., & Stückle, D. (2014) · Hormone Research in Paediatrics · doi:10.1159/000367980 · Cited by 1
Gut Hormones in Pregnancy and Lactation
Shim, J., & Yu, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00007-6 · Cited by 1
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_3 · Cited by 1
Metabolic status is not related to dietary acid load in polycystic ovary syndrome
Omma, T., ZENGİN, F. H., AYDOĞMUŞ, S., & Çulha, C. (2022) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · doi:10.20492/aeahtd.1069778 · Cited by 1
Fatima, Q., Jeelani, H., Abass, S., Farooq, M., & Rashid, F. (2023) · Springer eBooks · doi:10.1007/978-981-99-2193-5_9 · Cited by 2
The Role of Endoscopy in Management of Infertility
Daru, J., & Keresztúri, A. (2012) · InTech eBooks · doi:10.5772/51094 · Cited by 1
Association between serum levels of Adipokines and Polycystic Ovary Syndrome
Razavi, S. A., Hashemi, F., Emadi, M., Naghmeh, S., Haghighi, S., & Hedayati, M. (2015) · Bimonthly Journal of Hormozgan University of Medical Sciences · Cited by 1
Villarroel, C., Henríquez, S., Kohen, P., & Devoto, L. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_7 · Cited by 1
SRI 2023: Scientific Program & Abstracts
Perrella, S. L., McEachran, J., Rea, A., Prosser, S. A., Wlodek, M. E., & Geddes, D. T. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01211-1 · Cited by 2
Rola adiponektyny w rozrodzie samic
Drwal, E., & Rak, A. (2014) · Jagiellonian University Repository (Jagiellonian University)
Ramírez, C. A. V., Miranda, C. A. C., & Pulido, E. H. (2013)
Cardiovascular risk in young women with Polycystic OvarySyndrome
Coulson, R.-M. K. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Vivas, C., Trujillo, P. C., Trujillo, G. G., & Gutiérrez, M. L. O. (2011) · CES Medicina
Type 2 Diabetes in Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2014) · Frontiers in diabetes · doi:10.1159/000357250
Toulis, K. A. (2012)
Babu, R. H., Soja, & Sreekumari, R. (2015)
Best Practice & Research Clinical Obstetrics and Gynaecology
Messinis, I. E., Messini, C. I., Anifandis, G., & Dafopoulos, K. C. (2015)
Bustamante-Zuluaga, C., Vergara-Quintero, F., & Díaz-Yúnez, I. (2013)
Kokosar, M. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Metabolic and Nutritional Impact on Endometrial Gene Expression and Reproductive Disorder
Diao, L., Cai, S., Ding, J., & Zeng, Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-28584-5_13
STUDY OF SERUM IRISIN AND ITS ASSOCIATION WITH INSULIN RESISTANCE IN POLY CYSTIC OVARY SYNDROME
Kaushik, G. G., Chaudhary, P., & Sharma, A. (2021) · GLOBAL JOURNAL FOR RESEARCH ANALYSIS · doi:10.36106/gjra/8515120
Assessment of serum adiponectin levels in women with polycystic ovary syndrome
Patel, M. B., & Patel, D. R. C. (2021) · Obsgyne Review Journal of Obstetric and Gynecology · doi:10.17511/joog.2021.i02.01
Adipokines Network in Adolescent Girls with Polycystic Ovary Syndrome
Prokopowicz, Z., Stupar, S., & Zachurzok, A. (2013) · Pediatric Endocrinology · doi:10.18544/ep-01.12.04.1467
Role of BMI in PCOS Towards Cardiovascular Risk FactorsPreprint
Arshad, F.-A., Mehmood, R., Kausar, N., Bibi, A., & Khan, M. A. (2020) · Research Square · doi:10.21203/rs.3.rs-52960/v1
Dieta chetogenica, fertilità femminile e sindrome dell’ovaio policistico
Barrea, L., Verde, L., Tarsitano, M. G., & Muscogiuri, G. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01120-6
Iskandar, A. F., Widjanarko, N. D., Suryatenggara, F. G., Sylfiasari, R., Leonardo, L., Surya, N. D., & Ardianto, C. (2023) · Siriraj Medical Journal/San Sirirat · doi:10.33192/smj.v75i12.265452
Serum Adiponectin Marker in Women with Polycystic Ovary Syndrome
Kadhim, Y. I., Al-Tu’ma, F. J., & Rasoul, N. S. (2024) · kerbala journal of pharmaceutical sciences · doi:10.62472/kjps.v14.i23.22-30
Bondili, S. (2025) · i-manager s Journal on Life Sciences · doi:10.26634/jls.4.1.22112
Gut Hormones in Pregnancy and Lactation
Shim, J., & Yu, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00033-8
Ahn, H.-W., Kim, H.-G., Lee, J.-S., Kim, Y.-J., & Lee, J.-Y. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121605
Barbe, A. (2020) · theses.fr (ABES) · doi:10.70675/a1929a18zc99dz4f74zb8f8z614bf9e123e9
Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
Bongrani, A. (2022) · theses.fr (ABES) · doi:10.70675/1b281dcdz1f16z4985z95f8z0706a492c996
The skin as an external marker of systemic inflammatory and endocrine dysfunction
Dennison, T. (2026) · Journal of Aesthetic Nursing · doi:10.12968/joan.2026.0031
Cardiometabolic and Pregnancy-Related Complications in PCOS
Cardozo, L. L. Y., Abdelhameed, A. M., Eissa, M., & Romero, D. G. (2026) · Physiology in health and disease · doi:10.1007/978-3-032-26472-5_14
Uncovering the Metabolic Origins of Polycystic Ovary Syndrome
Iyer, P. J., Reza, H., Chitteti, N., Singh, A., Goyal, R., Saiyad, S. S., Raj, A. E. R. S., Singla, N., Vats, B., Kamaladasan, D., et al. (2026) · Cureus · doi:10.7759/cureus.114165
“Lower adiponectin levels, linked more closely to IR than to testosterone, are consistently seen in women with PCOS after adjusting for BMI, and altered subcutaneous fat handling may explain the hyperleptinemia often observed in lean PCOS [48].”
李红涛, Yin, T., Wang, Y., Wang, Y., Xu, N., Yi, W., & Yang, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1978249
“Adipokine fi ndings also vary (90 – 93); no marker identi fi es a clinical psychometabolic endotype (94).”
Güneşli, I., Aksun, M. S., & Yıldız, B. O. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-03047-3
Padder, K. A., Ganie, M., Jahan, N., Yousuf, M. A., Sehar, T., Bhat, M. A., Buhroo, S. A., Muzaffar, S., Majeed, S., Dar, R. A., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1996827
Estados hiperandrogénicos: revisión de la literatura Hyperandrogenic states: a literature review
Villarreal-Tordecilla, G. A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals)
Metadata
- Authors
- Toulis, K. A., Goulis, D. G., Farmakiotis, D., Georgopoulos, N. A., Katsikis, I., Tarlatzis, B. C., Papadimas, I., & Panidis, D.
- Affiliations
- Aristotle University of Thessaloniki (GR)
- University of Patras (GR)
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2009
- Volume
- 15
- Issue
- 3
- Pages
- 297-307
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2131241159
- Cited by
- 262
- References
- 72
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 14 · 2021: 20 · 2020: 19 · 2019: 13 · 2018: 12 · 2017: 17 · 2016: 10 · 2015: 21 · 2014: 17 · 2013: 23 · 2012: 25
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Warwick
- University of Adelaide
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, adiponectin, insulin resistance, testosterone, obesity, body mass index, high molecular weight adiponectin
- MeSH terms
- Female, Humans, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Regression Analysis, Testosterone, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review